Page last updated: 2024-08-23

phosphotyrosine and verapamil

phosphotyrosine has been researched along with verapamil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, MS; Bernstein, KE; Sayeski, PP1
Hill, MA; Murphy, TV; Spurrell, BE1
Belloc, F; Chollet, C; Goldman, JM; Lagarde, V; Mahon, FX; Melo, JV; Moreau-Gaudry, F; Reiffers, J1

Other Studies

3 other study(ies) available for phosphotyrosine and verapamil

ArticleYear
The role of Ca2+ mobilization and heterotrimeric G protein activation in mediating tyrosine phosphorylation signaling patterns in vascular smooth muscle cells.
    Molecular and cellular biochemistry, 2000, Volume: 212, Issue:1-2

    Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Cells, Cultured; Chelating Agents; Egtazic Acid; Heterotrimeric GTP-Binding Proteins; Muscle, Smooth, Vascular; Phosphoproteins; Phosphorylation; Phosphotyrosine; Sodium Fluoride; Verapamil

2000
Tyrosine phosphorylation following alterations in arteriolar intraluminal pressure and wall tension.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:3

    Topics: Angiotensin II; Animals; Antibody Specificity; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Colforsin; Endothelium, Vascular; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphorylation; Phosphotyrosine; Physical Stimulation; Rats; Rats, Sprague-Dawley; Tyrosine; Tyrphostins; Vanadates; Vasoconstriction; Vasodilator Agents; Verapamil

2001
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models.
    Blood, 2003, Mar-15, Volume: 101, Issue:6

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cell Death; Cell Division; Colony-Forming Units Assay; Cyclosporins; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; Genes, MDR; Humans; Imatinib Mesylate; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphotyrosine; Piperazines; Pyrimidines; Transfection; Tumor Cells, Cultured; Verapamil

2003